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ABSTRACT	42	
Background:	 In	 rodents	 the	 stimulation	 of	 adrenal	 progesterone	 is	 necessary	 for	 renal	43	
adaptation	 under	 potassium	 depletion.	 Here	 we	 sought	 to	 determine	 the	 role	 of	44	
progesterone	 in	 adrenal	 adaptation	 in	 potassium-depleted	 healthy	 human	 volunteers	 and	45	
compared	our	 findings	 to	data	 collected	 in	patients	with	Gitelman	 syndrome,	 a	 salt-losing	46	
tubulopathy.	47	
Methods:	Twelve	healthy	young	men	were	given	a	potassium-depleted	diet	for	7	days	at	a	48	
tertiary	referral	medical	center	(NCT02297048).	We	measured	by	LC-MS/MS	plasma	steroid	49	
concentrations	at	days	0	and	7	before	and	30	min	after	treatment	with	tetracosactide.	We	50	
compared	 these	 data	 to	 data	 collected	 in	 10	 Gitelman	 syndrome	 patients	 submitted	 to	51	
tetracosactide	test.		52	
Results:	 The	 potassium-depleted	 diet	 decreased	 plasma	 potassium	 in	 healthy	 subjects	 by	53	
0.3±0.1	 mmol/l,	 decreased	 plasma	 	 aldosterone	 concentration	 by	 	 50%	 (p=0.0332)and	54	
increased	 plasma	 17-hydroxypregnenolone	 concentration	 by	 45%	 (p=0.0232)	 without		55	
affecting	 other	 steroids.	 CYP17	 activity,	 as	 assessed	 by	 17-	 hydroxypregnenolone	56	
/pregnenolone	 ratio	 increased	 by	 60%	 (p=0.0389).	 As	 compared	 to	 healthy	 subjects	 ,	57	
Gitelman	 syndrome	 patients	 had	 3-fold	 higher	 plasma	 concentrations	 of	 aldosterone,	 11-58	
deoxycortisol	 (+30%),	 and	 delta	 4-androstenedione	 (+14%).Their	 post-tetracosactide	59	
progesterone	 concentration	 was	 2-fold	 higher	 than	 that	 of	 healthy	 subjects	 and	 	 better	60	
correlated	to	plasma	potassium	than	to	plasma	renin.		61	
Conclusion:	 The	 increase	 in	 17-hydroxypregnenolone	 concentration	 after	 mild	 potassium	62	
depletion	 in	 otherwise	 healthy	 human	 subjects	 suggests	 that	 17	 hydroxylation	 of	63	
pregnenolone	prevents	the	increase	in	progesterone	observed	in	potassium-depleted	mice.	64	
The	 unexpected	 over-response	 of	 non-mineralocorticoid	 steroids	 to	 tetracosactide	 in	65	
Gitelman	 syndrome	 subjects	 suggests	 that	 the	 adrenal	 system	 not	 only	 adapts	 to	 sodium	66	
depletion	but	may	also	respond	to	hypokalemia.		67	
246	WORDS	68	
	69	
70	
INTRODUCTION	71	
Potassium	 is	 the	most	abundant	cation	 in	organisms,	and	 the	equilibrium	between	 its	 low	72	
extracellular	 and	 high	 intracellular	 concentrations	 influences	 cellular	 processes	 and	73	
properties	such	as	membrane	resting	potential	and	cell	volume.	The	inability	to	maintain	this	74	
equilibrium,	 and	 particularly	 to	 restrain	 extracellular	 plasma	potassium	 concentration	 in	 a	75	
tight	 physiological	 range,	 is	 potentially	 life-threatening.	 The	 potassium	 balance	 is	76	
coordinated	 by	 mechanisms	 for	 potassium	 storage	 into	 and	 release	 from	 internal	 stores	77	
(internal	balance)	and	mechanisms	that	regulate	retention	and	excretion	(external	balance)	78	
[1].	 In	 this	 complex	 regulatory	 system,	 the	 kidney,	mainly	 the	 distal	 part	 of	 the	 nephron,	79	
plays	an	important	role.	In	steady-state	conditions,	renal	excretion	of	potassium	is	similar	to	80	
potassium	 intake.	The	distal	nephron	excretes	potassium	through	ROMK	and	BK	channels,	81	
which	 require	 a	 favorable	 electrical	 gradient	 generated	 by	 the	 activity	 of	 the	 amiloride-82	
sensitive	Na+	channel	ENaC	[2,	3].	Potassium	reabsorption	is	mediated	by	the	H,K-ATPases,	83	
mainly	the	isoform	HKA2	[4].	Excretion	and	reabsorption	are	functional	under	physiological	84	
conditions	 [5].	 In	subjects	on	a	 low-potassium	diet	condition,	 the	renal	switch	 from	a	high	85	
rate	of	potassium	secretion	to	efficient	potassium	conservation	is	mediated	by	a	number	of	86	
complementary	 mechanisms:	 1)	 an	 increase	 in	 electroneutral	 (mediated	 by	 the	 Na-Cl	87	
cotransporter	 NCC)	 versus	 electrogenic	 (mediated	 by	 ENaC)	 Na+	 reabsorption	 [6];	 2)	 a	88	
decrease	 in	plasma	aldosterone	concentration,	which	 induces	a	decreased	activity	of	ENaC	89	
[7];	3)	inhibition	of	ROMK	through	a	pathway	dependent	on	reactive-oxygen	species	[8];	4)	90	
the	 progesterone-dependent	 stimulation	 of	 the	 HKA2	 [4,	 9];	 and	 5)	 the	 proliferation	 of	91	
tubular	epithelial	cells	of	the	distal	nephron,	which	occurs	in	chronic	conditions	[10].	92	
	93	
In	 rodents	 in	 a	 potassium-depleted	 state,	 there	 is	 stimulation	 of	 adrenal	 secretion	 of	94	
progesterone	and	progesterone-dependent	stimulation	of	HKA2	expression	suggesting	that	95	
progesterone	is	not	just	a	sex	hormone	[9,	11].	This	offers	a	new	promising	way	in	treating	96	
or	 preventing	 renal	 hypokalemia	 by	 stimulating	 potassium	 reabsorption	 rather	 than	97	
inhibiting	its	secretion.	This	potassium-sparing	effect	of	adrenal	progesterone	has	only	been	98	
described	in	rodent	while	the	stimulation	of	adrenal	Progesterone	synthesis	by	K	depletion	99	
may	 not	 be	 effective	 in	 human.	 Indeed,	 the	 presence	 in	 human	 adrenal	 gland	 of	 the	100	
cytochrome	p450	family	member	CYP17A1,	an	enzyme	that	is	not	expressed	in	rodent	[12],	101	
metabolizes	 progesterone	 into	 17-hydroxyprogesterone	 and	 may	 prevent	 progesterone	102	
accumulation	[13]	(Figure	1).		103	
		104	
To	address	the	role	of	progesterone	in	renal	adaptation	to	potassium	depletion	in	humans,	105	
we	 submitted	 healthy	 subjects	 to	 a	 potassium-depleted	 diet	 and	 studied	 their	 renal	106	
adaptation	 to	 potassium	 depletion,	 the	 changes	 induced	 in	 plasma	 adrenal	 steroid	107	
concentrations,	 and	 their	 responses	 to	 adrenocorticotropic	 hormone	 (ACTH)	 stimulation	108	
following	tetracosactide	(Synacthene®)	administration.	Finally,	plasma	adrenal	steroids	were	109	
quantified	 in	 patients	with	 chronic	 severe	 renal	 hypokalemia	 related	 to	 a	 congenital	 salt-110	
losing	tubulopathy,	the	Gitelman	syndrome.	111	
112	
	113	
SUBJECTS	AND	METHODS	114	
SUBJECTS	115	
The	 study	 was	 approved	 by	 the	 local	 Ethics	 Committee	 (P120906	 -	 CPP	 Ile	 de	 France	 VI,	116	
NCT02297048).	All	subjects	gave	informed	consent	for	genetic	analyses	before	participating	117	
the	study.	The	study	was	registered	on	clinical	trial	registry	(NCT02297048).	118	
	119	
The	twelve	healthy	subjects	 included	 in	 the	study	were	Caucasian	males	18	 to	35	years	of	120	
age.	 Inclusion	 criteria	were	 BMI	 ranging	 from	 18	 to	 30	 kg/m2,	 plasma	 ionogram	 and	 liver	121	
panel	within	normal	range,	estimated	glomerular	 filtration	rate	 	 (MDRD)	>	60	ml/min/1.73	122	
m2.	 Exclusion	 criteria	were	 recent	 (within	 7	 days)	 diarrhea,	 gastric	 or	 duodenal	 ulcer,	 any	123	
current	drug	other	than	acetaminophen,	drug	allergy	history	or	any	severe	allergy,	drug	or	124	
alcohol	abuse,	blood	hemoglobin	<	10	g/dl.		125	
	126	
The	ten	patients	with	renal	loss	of	potassium	were	Caucasian	males	18	to	75	years	old	with	127	
genetically	 proven	 Gitelman	 syndrome.	 Exclusion	 criteria	 were	 recent	 (within	 7	 days)	128	
diarrhea,	drug	allergy	history	or	any	severe	allergy,	or	blood	hemoglobin	<	10	g/dl.		129	
	130	
INVESTIGATIONS		131	
After	 a	 safety	 inclusion	 visit,	 healthy	 subjects	 were	 subjected	 twice	 to	 a	 7-day	 period	 of	132	
potassium	 depletion.	 Potassium	 depletion	 was	 induced	 by	 30	 g	 daily	 sodium	 polystyrene	133	
sulfonates	(Kayexalate®,	Sanofi-adventis	France)	over	two	days,	followed	by	5	days	under	a	134	
low-potassium	diet	(25	mmol/d).	We	attempted	to	maintain	a	constant	level	of	calories	and	135	
of	 sodium	 intake	 during	 the	 diet	 period.	 A	 safety	 end-study	 visit	 was	 performed	 a	 7-day	136	
washout	period	after	the	second	potassium-depletion	interval.	137	
	138	
The	 day	 before	 admission	 for	 each	 experimental	 visit,	 participants	 were	 asked	 to	 collect	139	
urine	for	measurement	of	24-h	urinary	output	and	determination	of	urinary	concentration	of	140	
electrolytes	 (Na,	K,	Cl,	and	creatinine)	and	of	steroid	metabolites.	At	 the	beginning	 (day	1,	141	
D1)	or	 the	end	of	potassium	depletion	 (day	7,	D7),	blood	samples	were	taken	before	drug	142	
administration	at	about	9:00	a.m.	after	an	overnight	fast	and	after	1	h	of	rest	in	the	sitting	143	
position	 (time	 H0).	 Additional	 blood	 samples	 were	 taken	 30	 min	 after	 intravenous	144	
administration	of	 250	µg	 tetracosactide	 (time	H1;	 Synacthene®,	 alfasigma).	 Samples	 at	H0	145	
allowed	 determination	 of	 plasma	 electrolytes	 including	 sodium,	 potassium,	 chloride,	146	
bicarbonate,	creatinine,	and	plasma	renin	concentration,	plasma	aldosterone,	plasma	ACTH,	147	
and	of	steroids.	At	H1,	plasma	renin	and	plasma	aldosterone	were	quantified.	The	patients	148	
with	Gitelman	syndrome	were	given	the	tetracosactide	test	once;	the	same	parameters	that	149	
were	 measured	 in	 the	 healthy	 volunteers	 were	 measured	 in	 the	 Gitelman	 syndrome	150	
patients.	151	
	152	
METHODS	153	
Plasma	 concentrations	 of	 a	 panel	 of	 15	 steroids	 were	 measured	 using	 a	 liquid	154	
chromatography	coupled	to	tandem	mass	spectroscopy	(LC-MS/MS)	assay	to	avoid	the	risk	155	
of	interference	between	steroids	as	previously	described	[14].	The	steroids	evaluated	were	156	
pregnenolone,	 progesterone,	 corticosterone,	 deoxycorticosterone	 (DOC),	 aldosterone,	 17-157	
hydroxypregnenolone,	17-hydroxyprogesterone,	11-deoxycortisol,	21-deoxycortisol,	cortisol,	158	
cortisone,	DHEA,	delta	4-androstenedione,	11-β-hydroxyandrostenedione,	testosterone.		159	
Plasma	renin	concentration	was	assessed	with	commercial	kit	(Renin	III	from	CisBio).	Urinary	160	
concentrations	 of	 cortisol	 and	 plasma	 concentrations	 of	 ACTH	 were	 determined	 using	161	
chemiluminescent	enzyme	immunoassays	(Immulite	2000	XPi,	Siemens	Healthineers).		162	
Routine	 plasma	 and	 urinary	 aldosterone	 concentrations	 were	 also	 assessed	 with	 a	163	
commercial	kit	(DPC	Coat-a-Count	assay	from	Diagnostic	Products	Corp).	164	
	165	
STATISTICAL	ANALYSIS		166	
Our	hypothesis	was	that	potassium	depletion	would	 increase	adrenal	progesterone	and/or	167	
17-hydroxyprogesterone	 synthesis.	 The	 primary	 outcome	 was	 the	 change	 induced	 by	168	
potassium	 depletion	 in	 the	 plasma	 progesterone	 concentration	 measured	 30	 min	 after	169	
intravenous	 administration	 of	 250	 µg	 tetracosactide.	 This	 was	 a	 pilot	 study	 without	170	
preliminary	data	in	humans,	therefore,	there	was	no	data	that	could	be	used	to	support	the	171	
calculation	 of	 necessary	 sample	 size	 for	 statistical	 significance.	 In	male	mice	 subjected	 to	172	
potassium	 depletion,	 there	 was	 a	 stimulation	 of	 progesterone	 production	 by	 300%	 [9].	173	
Assuming	only	a	50%	increase	 in	progesterone	after	potassium	depletion	(mean	difference	174	
+0.03	[IC95%	:	+0.02;	-0.08];p	<	0.2827),	an	estimated	standard	deviation	(SD)	of	0.05	pg/ml,	175	
and	a	 two-sided	 type	1	error	 rate	of	 0.05%,	 a	 sample	 size	of	 12	evaluable	 subjects	would	176	
yield	80%	power.	177	
	178	
Analysis	of	variance	for	normally	distributed	variables	or	the	Kruskal-Wallis	non-parametric	179	
test	 for	 non-normally	 distributed	 variables	 were	 used	 to	 compare	 the	 characteristics	180	
between	genotypes.	In	most	cases,	data	were	log-transformed	when	they	were	not	normally	181	
distributed.	 To	 compare	 values	 from	 D0	 to	 D7	 or	 from	 H0	 to	 H1,	 paired	 t	 tests	 were	182	
performed,	whereas	independent	sample	t	tests	were	used	to	compare	values	of	Gitelman	183	
patients	with	values	of	healthy	subjects.	All	analyses	were	carried	out	using	SAS	Statistical	184	
Software	(version	9.4,	SAS	Institute),	and	p	<	0.05	was	considered	to	be	significant.	Results	185	
are	expressed	as	median	[IQR:	Q1;Q3].	186	
	187	
RESULTS	188	
EFFECT	OF	POTASSIUM	DEPLETION	IN	HEALTHY	SUBJECTS	189	
As	 expected,	 when	 values	 were	 compared	 for	 healthy	 subjects	 on	 D0	 versus	 D7,	 plasma	190	
potassium	concentration	decreased	(mean	difference	0.3	±	0.1	mmol/l,	p=	0.0180,	Table	1),	191	
and	 subjects	 became	 slightly	 hypokalemic	 without	 change	 in	 plasma	 concentrations	 of	192	
sodium,	chloride,	bicarbonate,	creatinine,	or	estimated	glomerular	 filtration	rate	 (Table	1).	193	
Potassium	 depletion	 induced	 a	 decrease	 (by	 a	 factor	 of	 2)	 in	 daily	 urinary	 excretion	 of	194	
potassium	 (Table	 1)	 without	 affecting	 daily	 urinary	 excretion	 or	 fractional	 excretion	 of	195	
sodium	(Table	1).		196	
	197	
As	measured	by	 immunoassay,	plasma	aldosterone	 concentration	and	urinary	aldosterone	198	
excretion	 decreased	 by	 -55%	 ([IC95:	 -72%;-28%];	 p=0.0068)	 and	 -69%	 ([IC95:	 -80%;	 -51%];	199	
p=0.0001),	respectively,	from	D0	to	D7	in	healthy	subjects	(Table	1).	This	is	likely	due	to	the	200	
inhibitory	 effect	 of	 potassium	 depletion	 on	 aldosterone	 secretion	 since	 the	 plasma	 renin	201	
concentration	 was	 not	 significantly	 affected	 (Table	 1).	 Plasma	 ACTH	 and	 urinary	 cortisol	202	
excretion	(nmol/mmol	creatinine)	(Table	1)	and	plasma	cortisol	(Table	2)	were	not	affected	203	
by	potassium	depletion.	204	
	205	
A	week	of	potassium	depletion	did	not	affect	any	of	 the	plasma	steroid	concentrations	as	206	
assessed	 by	 LC-MS/MS	 (Table	 2,	 healthy	 subjects,	 D0	 vs.	 D7)	 with	 the	 exceptions	 of	207	
aldosterone,	 which	 decreased	 by	 -50%	 ([IC95%	 -80%;-10%];	 p=0.0332)and	 17-208	
hydroxypregnenolone,	 which	 increased	 by	 45%	 [IC95%	 9%;	 +67%];	 p=0.0232).	 Of	 note,	209	
concentrations	 of	 plasma	 progesterone	 (mean	 difference	 20%	 [IC95	 %	 -24%;	 +49%],	210	
p=0.283)	 and	 its	metabolite	 17-hydroxyprogesterone	 (mean	difference	 +11%	 [IC95	%	 -9%;	211	
+28%],	p	0.237)	were	similar	before	and	after	a	week	of	potassium,	depletion	(Table	2).		212	
	213	
We	 then	 estimated	 enzymatic	 activity	 of	 adrenal	 steroidogenesis	 by	 calculating	 the	 ratio	214	
between	 the	 product	 and	 substrate	 of	 enzymes	 (Figure	 1,	 Supplemental	 Table	 1).	 This	215	
analysis	identified	two	changes	in	important	steps	of	the	steroidogenesis	in	healthy	subjects	216	
after	 potassium	 depletion.	 First,	 the	 activity	 of	 CYP11B2,	 estimated	 as	 the	 ratio	 of	217	
aldosterone	 to	 corticosterone	 was	 3-4-fold	 decreased.	 Second,	 less	 expectedly,	 CYP17	218	
activity,	 estimated	 as	 the	 ratio	 of	 17-hydroxypregnolone	 to	 pregnolone,	was	 increased	 by	219	
60%.	The	stimulation	of	CYP17	was	associated	with	no	change	in	estimated	activity	of	3-β-220	
hydroxysteroid	 dehydrogenase	 (3βOHSD)	 in	 the	 glomerulosa	 and	 a	 decrease	 in	 estimated	221	
3βOHSD	 activity	 in	 the	 fasciculata,	 which	 prevented	 conversion	 of	 17-hydroxypregnolone	222	
into	17-hydroxyprogesterone.		223	
	224	
Intravenous	 administration	 of	 250	 µg	 tetracosactide	 led	 to	 a	 2-fold	 increase	 in	 plasma	225	
cortisol,	 a	 4-fold	 increase	 in	 plasma	 aldosterone,	 and	 a	 significant	 increase	 in	 all	 plasma	226	
hormonal	 concentrations	 except	 renin,	 testosterone,	 and	 cortisone	 (Table	 2).	 Post	227	
tetracosactide	concentrations	of	steroids	measured	under	usual	diet	(D0)	and	after	a	week	228	
under	low	potassium	diet	(D7)	were	similar.	229	
	230	
EFFECT	OF	CHRONIC	POTASSIUM	DEPLETION	231	
The	 effect	 of	 a	 severe	 and	 chronic	 depletion	 of	 potassium	 was	 addressed	 in	 patients	232	
suffering	of	a	salt	and	potassium	loosing	nephropathy,	the	Gitelman	syndrome	(GS)	(OMIM	233	
#263800).	 As	 shown	 in	 Table	 1,	 patients	 with	 GS	 were	 older	 than	 healthy	 subjects	 (p<	234	
0.0001)	but	had	similar	BMI	(p=0.1765),	and	their	diastolic	blood	pressure	was	slightly	higher	235	
than	that	of	healthy	subjects	(Table	1).	Patients	with	the	salt-losing	tubulopathy	had	marked	236	
activation	 of	 the	 renin	 angiotensin-aldosterone	 system	 and	 high	 sodium	 intake	 (as	237	
demonstrated	by	higher	 levels	of	sodium	excretion)	as	compared	to	controls	(Tables	1	and	238	
3).	They	had	marked	hypokalemia,	abnormal	levels	of	potassium	excretion	(i.e.,	K	excretion	>	239	
40	mmol/24	h	and	fractional	excretion	of	K	higher	than	5%).	Their	plasma	ACTH	was	similar	240	
to	that	of	healthy	subjects	(Table	1).		241	
Despite	 their	 chronic	 hypokalemia,	 GS	 patients	 did	 not	 display	 any	 differences	 in	 pre-242	
tetracosactide	 plasma	 steroid	 concentrations	 compared	 to	 healthy	 subjects	 with	 the	243	
exceptions	 of	 lower	 levels	 of	 aldosterone	 (mean	 difference	 69%	 [IC95	 %	 +33%;	 +86%],	 p	244	
0.0046)	 and	 of	 higher	 levels	 of	 11-deoxycortisol	 and	 of	 delta	 4-androstenedione	 (mean	245	
differences	 +44%	 [IC95%	 +1%;	 +68%],	 p=0.0471	 and	 19%	 [IC95	 %	 +0%;	 +34%],	 p=0.0485,	246	
respectively)	(Table	2).		247	
	248	
GS	 patients	 had	 a	 stronger	 response	 to	 tetracosactide	 than	 healthy	 subjects	 (Table	 3).	 As	249	
expected,	 in	 GS	 patients	 post-tetracosactide	 plasma	 aldosterone	 concentration	 was	250	
markedly	higher	 than	 in	healthy	 subjects	 (+67%	 [+44%;	+80%],	p=0.0003).	 In	 addition,	 the	251	
post-tetracosactide	 concentrations	 of	 pregnenolone,	 progesterone,	 corticosterone,	 DOC,	252	
and	 11-deoxycortisol	 were	 about	 40%	 higher	 in	 GS	 patients	 than	 in	 healthy	 subjects,	253	
whereas	cortisol	and	delta	4-androstenedione	levels	were	20-30%	higher.	This	exacerbated	254	
response	 to	 tetracosactide	 could	 be,	 depending	 of	 the	 steroid,	 related	 either	 to	 the	255	
observed	 chronic	 stimulation	 of	 angiotensin	 II	 or	 to	 chronic	 potassium	 depletion.	 To	256	
distinguish	 between	 these	 possibilities,	 we	 calculated	 the	 correlation	 between	 post-257	
tetracosactide	plasma	steroid	 levels	and	plasma	 renin	 (which	are	high	when	angiotensin	 II	258	
activity	 is	 high)	 or	 plasma	potassium	 values.	We	 found	 that	 progesterone,	 corticosterone,	259	
DOC,	and	aldosterone	were	correlated	with	both	plasma	renin	and	plasma	potassium	levels	260	
(Supplemental	Table	2,	Figure	2	A-D),	whereas	pregnenolone	and	delta	4-androstenedione	261	
only	 correlated	 with	 plasma	 potassium	 concentration	 (Figure	 2	 E-H).	 Interestingly,	262	
aldosterone	 (Figure	 2	 A-B)	 and	DOC	 (Supplemental	 Table	 2)	 best	 fitted	with	 plasma	 renin	263	
concentration,	whereas	progesterone	best	fitted	with	plasma	potassium	level	(Figure	2	C-D).	264	
	265	
DISCUSSION	266	
MILD	REDUCTION	OF	POTASSIUM	INTAKE	DOES	NOT	INFLUENCE	PROGESTERONE	AND	17-267	
HYDROXYPROGESTERONE	CONCENTRATIONS	IN	MEN		268	
Although	 it	 is	 clear	 that	 steroid	 production	 by	 the	 adrenal	 gland	 changes	 in	 response	 to	269	
sodium	 and	 potassium	 content	 of	 the	 diet	 [15,	 16],	 almost	 nothing	 was	 known	 about	270	
adaptation	of	humans	to	a	low	potassium	diet	except	that	plasma	aldosterone	concentration	271	
falls	markedly	after	2-3	days	of	potassium	depletion	[17].	Elabida	et	al.	demonstrated	in	mice	272	
that	potassium	depletion	but	not	sodium	depletion,	led	to	increase	in	adrenal	progesterone	273	
production	[9].	Potassium	depletion	induced	an	increased	expression	of	steroidogenic	acute	274	
regulatory	 protein	 (StAR),	 CYP11A1,	 and	 3βHSD1	 and	 was	 associated	 with	 decreased	 in	275	
CYP11B1	expression	(a	key	enzyme	in	corticosterone	synthesis)	and	 in	CYP11B2	expression	276	
(a	key	enzyme	for	aldosterone	synthesis).	Using	a	mathematical	model	of	steroidogenesis	in	277	
mice,	Elabida	et	al.	predicted	that	potassium	depletion	should	result	in	an	increase	in	plasma	278	
progesterone,	a	prediction	confirmed	experimentally	in	male	mice	and	male	men	[9].	In	mice		279	
progesterone	 regulates	 renal	 potassium	 handling	 both	 in	 males	 and	 females	 under	280	
potassium	 restriction,	 independently	 of	 its	 role	 in	 reproduction,	 and	 this	 adrenal	281	
progesterone	was	 required	 for	 full	 adaptation	 to	potassium	depletion	 [9].	 The	mechanism	282	
was	 mediated	 by	 stimulation	 of	 the	 H,K-ATPase	 type	 2	 and	 was	 prevented	 by	 the	283	
progesterone	 receptor	 antagonist	 RU486.	 These	 results,	 however,	 were	 not	 immediately	284	
transferable	 to	 man	 since	 human	 adrenal	 steroidogenesis	 strongly	 differs	 from	 that	 of	285	
rodents	 as	 humans	 express	 CYP17,	 which	 metabolizes	 progesterone	 into	 17-286	
hydroxyprogesterone,	 although	Elabida	et	 al.	 also	established	a	weak	 correlation	between	287	
plasma	progesterone	in	men	and	their	potassium	intake	[9].			288	
	289	
To	 directly	 address	 the	 contribution	 of	 progesterone	 on	 renal	 adaptation	 to	 potassium	290	
depletion	in	human,	we	induced	potassium	depletion	in	healthy	men.	Although	we	did	not	291	
measure	 intracellular	 potassium	 levels,	 the	 marked	 inhibition	 of	 plasma	 and	 urinary	292	
aldosterone	 concentrations	 were	 indicative	 of	 a	 state	 of	 potassium	 depletion.	 	 At	 the	293	
beginning	 and	 the	 end	 of	 the	 period,	 we	 performed	 a	 tetracosactide	 test	 to	 stress	 the	294	
adrenal	 response	 to	 potassium	 depletion	 and	 potentially	 reveal	 subtle	 modifications	 in	295	
adrenal	steroidogenesis.	Neither	progesterone	nor	17-hydroxyprogesterone	concentrations	296	
measured	 before	 or	 after	 tetracosactide	 administration	 were	 affected	 by	 potassium	297	
restriction.	 However	 the	 potassium	 depletion	 we	 induced	 may	 have	 been	 too	 weak	298	
(decrease	by	2-fold	of	potassium	intake)	or	too	short	(7	days)	or	both	as	compared	to	what	299	
has	been	done	in	mice	(decrease	by	20-fold	of	potassium	intake	for	1	week).	In	male	mice,	300	
the	increase	of	progesterone	appears	to	stimulate	potassium	reabsorption	to	counteract	the	301	
deleterious	effect	of	prolonged	potassium	restriction.	This	step	was	not	observed	in	healthy	302	
subjects	 in	 our	 present	 study.	 In	 addition,	 the	 presence	 of	 a	 CYP17A	 activity	 in	 human	303	
adrenal	 glands	 may	 have	 prevented	 progesterone	 accumulation.	 In	 support	 of	 this,	 we	304	
observed	 a	 significant	 50%	 increase	 in	 17-hydroxypregnenolone	 and,	 unexpectedly,	 the	305	
estimated	CYP17	activity	 increased	by	60%.	Our	results	suggest	that	this	 increase	 in	CYP17	306	
activity	 leads	 to	 17-hydroxypregnenolone	 accumulation	 but	 that	 conversions	 of	307	
pregnenolone	into	progesterone	and	17-hydroxypregnenolone	into	17-hydroxyprogesterone	308	
are	prevented	by	low	3βOHSD	activity	(Figure	1).		Our	study	was	powered	to	demonstrate	a	309	
50%	increase	in	plasma	progesterone	and	17-hydroxyprogesterone	concentrations,	whereas	310	
150	 subjects	 would	 be	 required	 to	 demonstrate	 that	 the	 observed	 20%	 increase	 in	 pre-311	
tetracosactide	progesterone	concentration	was	significant.		312	
	313	
PATIENTS	 WITH	 SALT-LOSING	 TUBULOPATHIES	 HAD	 ALTERED	 ADRENAL	 RESPONSE	 TO	314	
TETRACOSACTIDE	BUT	UNAFFECTED	PROGESTERONE	METABOLISM	315	
We	also	studied	the	plasma	steroid	profile	in	patients	with	a	congenital	renal	loss	of	sodium	316	
and	 potassium	 due	 to	 a	 Gitelman	 syndrome.	 These	 patients	 had	 a	 severe	 chronic	317	
hypokalemia	 (median	 2.7	 mmol/l,	 Table	 1),	 a	 renal	 loss	 of	 sodium,	 resulting	 in	 marked	318	
stimulation	 in	plasma	renin	and	aldosterone	concentrations,	and	high	potassium	 intake.	 In	319	
contrast	to	observations	in	rodents,	despite	profound	hypokalemia,	GS	patients	displayed	a	320	
hyperaldosteronism	 in	 response	 to	 their	 loss	 of	 salt	 and	 are	 under	 potassium	321	
supplementation	 to	 limit	 their	 hypokalemia.	 The	 levels	 of	 plasma	 progesterone	 and	 17-322	
hydroxyprogesterone	were	similar	to	those	observed	in	healthy	subjects.	Interestingly,	after	323	
treatment	with	 tetracosactide,	 levels	 of	many	 steroids	were	more	elevated	 in	GS	patients	324	
than	 in	healthy	 subjects.	 These	 results	 indicate	 that	patients	with	GS	have	a	higher	ability	325	
than	 healthy	 subjects	 to	 respond	 to	 ACTH	 stimulation	 in	 order	 to	 promote	 steroid	326	
production.	 Since,	 these	 patients	 displayed	 stimulation	 of	 their	 renin-angiotensin-327	
aldosterone	 system	 (Tables	 2	 and	 3),	 we	 suggest	 that	 the	 presence	 of	 high	 levels	 of	328	
angiotensin	 II	 sensitizes	 the	adrenal	 glands	of	GS	patients	 to	ACTH.	This	 synergic	effect	of	329	
angiotensin	 II	 and	ACTH	on	 steroid	 production	was	 originally	 documented	 about	 35	 years	330	
ago	 [18].	 	 Indeed,	 angiotensin	 II	 not	 only	 increases	 the	 expression	 of	 CYP11B2,	 but	 also	331	
indirectly	 stimulates	 the	 activities	 of	 3βHSD2	 and	 CYP21	 enzymes	 [19].	 GS	 patients	 are,	332	
however,	in	a	paradoxical	situation	since	they	exhibit	a	profound	hypokalemia	that	probably	333	
counteracts,	 at	 least	 partially,	 the	 effect	 of	 angiotensin	 II.	 When	 ACTH	 is	 given	 to	 GS	334	
patients,	 it	 disrupts	 this	 fragile	 equilibrium	 and	 reveals	 a	 “hidden”	 hyperactivity	 of	 the	335	
adrenal	glands,	which	produce	steroids	like	progesterone	with	a	good	correlation	to	plasma	336	
potassium	level.			337	
In	 conclusion,	 we	 provide	 evidence	 that	 potassium	 depletion	 induced	 in	 healthy	 men	338	
enhances	 CYP17	 adrenal	 activity,	 blunting	 progesterone	 accumulation.	 It	 is	 important	 to	339	
note	that	our	data	do	not	exclude	the	possibility	that	an	adrenal	steroid-dependent	pathway	340	
is	 involved	 in	 adaptation	 to	more	 severe	potassium	depletion.	We	unexpectedly	observed	341	
over-response	to	tetracosactide	of	non-mineralocorticoid	steroids	in	GS	patients	suggesting	342	
that	adrenal	glands	not	only	adapt	to	sodium	depletion	but	also	to	potassium	depletion	343	
	344	
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	399	
LEGENDS		400	
FIGURE	1:	 Effect	 of	 potassium	depletion	on	 adrenal	 steroidogenesis.	 	Activities	 of	 the	401	
main	enzymes	of	adrenal	steroidogenesis	were	estimated	by	calculation	of	the	product	to	402	
substrate	ratios,	indicated	in	the	circles.	Significant	changes	after	potassium	depletion	are	403	
indicated	by	red	circles	when	enzymatic	activity	was	enhanced	and	by	grey	dashed	circles	404	
when	 activity	 was	 inhibited.	 As	 expected,	 potassium	 depletion	 dramatically	 depressed	405	
CYP11B2	 activity	 (and	 thus	 aldosterone	 production).	 It	 also	 increased	 CYP17	 activity,	406	
leading	 to	 an	 increase	 in	 17-hydroxypregnenolone,	 and	 reduced	 3bHSD	 activity	 in	 the	407	
fasciculate	 preventing	 transformation	 of	 17-hydroxypregnenolone	 into	 17-408	
hydroxyprogesterone.	The	decrease	 in	17-20	liase	 in	the	reticularis	was	not	sufficient	to	409	
prevent	 DHEA	 accumulation	 (due	 to	 transformation	 of	 17-hydroxy	 pregnenolone	 into	410	
DHEA).	411	
	412	
FIGURE	2:	Correlation	of	post-tetracosactide	concentrations	of	plasma	hormones	with	413	
plasma	 renin	 or	 plasma	 potassium	 concentrations.	 The	 individual	 concentrations	 of	414	
plasma	hormones	were	measured	after	administration	of	250	µg	tetracosactide	in	healthy	415	
subjects	 under	 normal	 diet	 or	 in	Gitelman	patients	 and	 correlated	 to	 the	 plasma	 renin	416	
concentration	 or	 the	 plasma	 K	 level.	Nonparametric	 Spearman	 coefficient	 r	 [CI95%]	417	 and	p	values	of	the	correlations	were	calculated	using	Prism	8	software.	418	
	419	
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Table	 1:	 Baseline	 characteristics	 of	 healthy	 subjects	 and	 GS	 patients	 and	 effects	 of	 potassium	423	
depletion	on	hemodynamic,	plasma,	and	urinary	electrolytes	and	hormones.a		424	
	425	
	 	
Healthy	subjects	(n=12)	 GS	patients	(n=10)	
Parameters	
	
D0	 D7	
	Age		 yrs	 27.4	[22.6;30	.7]	 -	 46.2	[39.4;49.5]	c	
BMI	 kg/m2	 23.9	[20.8;25.4]	 -	 25.2	[22.5;27.2]	
	 	 	 	 	
SBP	 mmHg	(H0)	 121	[115;127]	 118	[117;127]	 120	[115;122]	
DBP	 mmHg	(H0)	 65	[64;70]	 70	[65;74]	 81	[74;85]c	
	
Plasma	
	 	
	
	
Sodium	 mmol/L	 139	[137;141]	 140	[138;141]	 138	[137;139]	
K	 mmol/L	 3.6	[3.5;3.9]	 3.4	[3.2;3.7]b	 2.7	[2.0;3.1]c	
Cl	 mmol/L	 105	[103;106]	 104	[103;106]	 97	[94;98]c	
Bicarbonate	 mmol/L	 27	[26;28]	 27	[27;29]	 87	[72;96]	
eGFR	(MDRD)	
	
ml/min/1.73m²	 103	[83;112]	 100	[90;108]	
	
	 	 	 	 	
ACTH		 pg/mL	(H0)	 18	[14;28]	 19	[14;27]	 18	[13;28]	
Renin		 mUI/L	(H0)	 14	[12;16]	 12	[6;17]	 159	[96;200]c	
Aldosterone	 pg/mL	(H0)	 67	[40;83]	 23	[17;34]	a	 237[67;359]	c	
	 	 	 	 	
Urine	
	 	
	 	
Urine	output	 l/24h	 1.7	[0.8;2.4]	 1.5	[1.1;2.0]	 2.2	[1.7;2.4]	
Na	 mmol/24h	 136	[80;200]	 155	[103;192]	 231	[187;305]	c	
K	 mmol/24h	 57	[36;72]	 25	[21;32]	b	 117	[98;138]	c	
Cl	 mmol/24h	 147	[89;185]	 163	[105;198]	 304	[256;383]	c	
Creatinine	 mmol/24h	 14	[12;18]	 16	[15;18]	 15	[13;18]	
Na	excretion	 %	 0.5	[0.4;0.6]	 0.5	[0.5;0.6]	 0.9	[0.7;1.1]	c	
K	excretion	 %	 8.3	[5.8;10.6]	 3.6	[2.9;3.9]	b	 23.2	[19.1;29.1]	c	
Aldosterone/creatinine	 ng/mmol	 0.52	[0.33;0.63]	 0.19	[0.07;0.26]	b	 1.56	[0.96;3.07]	c	
Cortisol/creatinine	 ng/mmol	 14	[10;25]	 16	[12;27]	 43	[42;44]	
a	Potassium	depletion	was	induced	by	30	g	daily	polystyrene	sulfonates	for	two	days,	followed	by	5	426	
days	of	a	 low-potassium	diet	 (25	mmol/day).	Blood	and	urine	samples	were	taken	at	baseline	 (D0)	427	
and	day	7	(D7).	Results	are	median	[IQR]	and	p	value	of	geometric	means.	b	p	<	0.05	D7	vs.	D0.	c	p	<	428	
0.05	 GS	 vs.	 healthy	 subjects	 D0.	 Abbreviations:	 BMI,	 body	 mass	 index;SBP,	 systolic	 blood	429	
pressure;DBP,	 diastolic	 blood	 pressure;eGFR,	 estimated	 glomerular	 filtration	 rate;ACTH,	430	
adrenocorticotropic	hormone.			431	
	432	
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